These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2954396)

  • 1. [A combined perfusion-compartmental pharmacokinetic model used to estimate presystemic metabolism of erythromycin in dogs].
    Huang SK; Wu X; Hang S; Yang R; Zhuo HT
    Zhongguo Yao Li Xue Bao; 1986 Jul; 7(4):342-6. PubMed ID: 2954396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etimizol absorption from the small intestine in dogs: the dependence on dosage].
    Trnovec T; Faberová V; Piotrovskiĭ LB; Durisová M; Gabauer I
    Biull Eksp Biol Med; 1986 Dec; 102(12):729-30. PubMed ID: 3801627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Erythromycin in man.
    Wilson JT; van Boxtel CJ
    Antibiot Chemother (1971); 1978; 25():181-203. PubMed ID: 27136
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of acid protective coating on absorption of erythromycin at oral administration].
    Koroleva VG; Belozerova OP; Vasil'ev VK; Stepnaia VE
    Antibiotiki; 1969 Dec; 14(12):1084-8. PubMed ID: 5371175
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cephalexin pharmacokinetics].
    Koroleva VG; Vasil'ev VK; Danilova VI; Firsov AA
    Antibiotiki; 1981 Mar; 26(3):113-6. PubMed ID: 7235651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [First-pass effect as a therapeutic problem].
    Danek A
    Pol Tyg Lek; 1983 Apr; 38(16):511-4. PubMed ID: 6634498
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in rats.
    Bramer SL; Au JL; Wientjes MG
    J Pharmacol Exp Ther; 1993 May; 265(2):731-8. PubMed ID: 8496819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data.
    Yamano K; Yamamoto K; Katashima M; Kotaki H; Takedomi S; Matsuo H; Ohtani H; Sawada Y; Iga T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):443-52. PubMed ID: 11259329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Absorption and metabolism of antibiotics. Residues in the tissues].
    Ferrando R
    Bibl Nutr Dieta; 1968; 10():90-125. PubMed ID: 4868400
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique.
    von Richter O; Greiner B; Fromm MF; Fraser R; Omari T; Barclay ML; Dent J; Somogyi AA; Eichelbaum M
    Clin Pharmacol Ther; 2001 Sep; 70(3):217-27. PubMed ID: 11557909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs.
    Gu Y; Wang GJ; Sun JG; Jia YW; Wang W; Xu MJ; Lv T; Zheng YT; Sai Y
    Food Chem Toxicol; 2009 Sep; 47(9):2257-68. PubMed ID: 19524010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
    Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR
    Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of uremic toxins on hepatic uptake and metabolism of erythromycin.
    Sun H; Huang Y; Frassetto L; Benet LZ
    Drug Metab Dispos; 2004 Nov; 32(11):1239-46. PubMed ID: 15286055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine.
    Wu CY; Benet LZ; Hebert MF; Gupta SK; Rowland M; Gomez DY; Wacher VJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):492-7. PubMed ID: 7586942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition.
    Lo MW; Effeney DJ; Pond SM; Silber BM; Riegelman S
    J Pharmacol Exp Ther; 1982 May; 221(2):512-5. PubMed ID: 7077541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmakokinetics of erythromycin.
    Knothe H; Dette GA
    Scott Med J; 1977 Dec; 22(5):397-400. PubMed ID: 601558
    [No Abstract]   [Full Text] [Related]  

  • 18. Monte Carlo simulation of an ethanol pharmacokinetic model.
    Whitmire D; Cornelius L; Whitmire P
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1484-93. PubMed ID: 12394281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bariatric surgery on erythromycin absorption.
    Pinchiera JC; Prince RA; Mason EE
    Am J Hosp Pharm; 1981 Feb; 38(2):232. PubMed ID: 7211889
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
    Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.